Our capabilities in terms of procedures and facilities to store and ship cold chain products are approved and licensed by the MHRA through on-site inspections. We have an effective Cold chain product storage room at our warehouse facility which has 24/7 temperature monitoring system with appropriate warning functions in case of any discrepancy in temperature. This is constantly monitored by our team at our warehouse. We have effective protocols in place which ensures the temperature is maintained for cold chain product storage.
We work with expert packaging suppliers to ensure most optimal and effective cold chain preservation during shipment of goods to our customers from start to finish. This ranges from using active and passive solutions which ensures the integrity of the product is protected during transit and arrives to the customer in its full integrity. All of our packaging solutions that we use are validated for GDP.
Good distribution practice (GDP) requires that medicines are obtained from the licensed supply chain and are consistently stored, transported and handled under suitable conditions, as required by the Marketing Authorisation (MA) or product specification.
GDP ensures that the quality of medicinal products is maintained throughout all stages of the supply chain from the site of manufacturer to the pharmacy or person authorised or entitled to supply medicinal products to the public.
All of our infrastructural and operational elements are in line with GDP requirements. These are the requirements we need to meet in order to comply with the MHRA.
Organisations that may have to comply with good manufacturing practice (GMP) and/or good distribution practice (GDP) include:
The General Pharmaceutical Council (GPhC) regulate pharmacists and pharmacies in the UK.
They work to assure and improve standards of care for people using pharmacy services.
Their role is to protect the public and give them assurance that they will receive safe and effective care when using pharmacy services.
They set standards for pharmacy professionals and pharmacies to enter and remain on our register.
The GPhC seek assurance that pharmacy professionals and pharmacies continue to meet our standards, including by inspecting pharmacies.
Through our work we help to promote professionalism, support continuous improvement and assure the quality and safety of pharmacy.
Pharma Medicare works and collaborates with globally known reliable couriers to deliver our orders to local and international clients based in the UK and globally. We fulfil orders ranging from low volume boxes to large batches via air, sea and road. Our systems and customer service team ensure live tracking of shipments by our customers and timely delivery to their final destinations.
We have contracts in place with airlines that meet standards of GDP and have the required infrastructure and trained staff to deal with pharmaceuticals. These airlines have an effective temperature monitoring system in place to ensure the integrity of the product is protected during transit. We can deliver to Europe, North America, South America, Africa, Asia and Oceania.
Pharma Medicare have Standard Operation Procedures (SOP’S) in place that are in line with GDP and MHRA requirements that are regularly reviewed by our trained staff. We have an effective quality management system in place which ensures that all standards are being met and conduct regular audits and inspections of our site. Our facilities have 24/7 camera surveillance system and security. We have multiple sensors that are monitoring temperature and humidity for optimum storage conditions at our warehouse.
We work and obtain medicines only with licensed suppliers and all goods are inspected for their authenticity and general condition by physical examination by our operations team. We take great caution in ensuring Falsified Medicines don’t enter the supply chan. Our fleet vehicles used for transportation are regularly inspected and accredited to ensure the quality of standards are maintained when transporting medicinal products.
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK.
Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development.
The agency is responsible for:
